- 01Reads project dataStages, timesheets, costs, tests and documents recorded in Paylists.
- 02Searches published workOpenAlex, Europe PMC, PubMed, arXiv, Crossref, OSTI, NASA NTRS, NIST and other sources.
- 03Recommends answersEach answer is supported by references for your team and R&D tax advisor to review.
What is the R&D aim of the project?
Lister recommended answerTo develop a human organoid culture process that produces sufficiently consistent cell composition, maturation and assay response across independent batches for repeatable experimental use.
What was the scientific or technological uncertainty?
- 01
Describe exactly which uncertainties you need to resolve
Lister recommended answerWhether changes to plating density, media composition, growth-factor timing and quality-control procedures can reduce batch-to-batch variability without removing biologically important characteristics of the organoids.
- 02
Describe what made it a project to resolve a specified uncertainty
Lister recommended answerOrganoid culture was already established, but published research showed substantial variability between cultures and laboratories. It was not readily predictable whether the proposed changes would achieve the required reproducibility for this particular biological model.
- 03
Describe the steps you plan to take to resolve them
Lister recommended answerCreate controlled protocol variants, run independent biological batches, measure cell composition and functional assay performance, compare variability and repeat the best-performing configuration using fresh material.
- 04
What difficulties are foreseen for the project
Lister recommended answerBiological variation can come from cell source, passage, matrix lot, growth factors, operator technique and differentiation timing, making it difficult to distinguish technical variation from genuine biological heterogeneity.
- 05
Information about any major changes to the aims, or new uncertainties that have been encountered, while running the project.
Lister recommended answerEarly testing may show that reducing one source of variation changes cell composition or maturation. The team may therefore need to modify media, timing or QC thresholds while retaining the original reproducibility objective.
- 06
How the uncertainties and other challenges were overcome (or not).
Lister recommended answerSuccessive protocol iterations would be compared across independent batches. If variability remained above the predefined threshold for particular cell lines or conditions, the uncertainty would remain unresolved for those conditions.
What advance in science or technology was sought?
- 01
A review of the current state of knowledge
Lister recommended answerPublished work showed that organoids can reproduce important biological characteristics but that reproducibility, robustness and standardisation remain significant limitations. Existing standardisation approaches did not guarantee the required performance for every organoid system.
- 02
How the project sought an advance in a qualifying area of science or technology
Lister recommended answerThe project sought a demonstrably more reproducible organoid-culture capability within a defined biological and experimental envelope, rather than simply establishing an organoid culture.
What was the result, and what evidence is still needed?
Result
Later independent batches achieved improved consistency under the tested protocol, although some biological conditions remained more variable than others.
Conclusion
The project may support an R&D advance where the evidence demonstrates a reproducibility capability that was not readily deducible from existing protocols.
Evidence still needed
Batch IDs, reagent lots, protocol versions, raw phenotype measurements, biological-versus-technical replicate definitions, failed cultures and a dated competent-professional conclusion.
Supporting references
Jensen & Little (2023), Organoids are not organs: Sources of variation and misinformation in organoid biology.
pmc.ncbi.nlm.nih.gov ↗Ludwig et al. (2023), ISSCR standards for the use of human stem cells in basic research.
pubmed.ncbi.nlm.nih.gov ↗Velasco et al. (2019), Individual brain organoids reproducibly form cell diversity of the human cerebral cortex.
pmc.ncbi.nlm.nih.gov ↗
What does Paylists record for this project, and who reviews it?
Paylists records the project stages, timesheets, costs, tests and documents, and Lister recommends an answer to each Additional Information Form question with supporting references. Your team, your competent professional and your R&D tax advisor can log in to review them.